NIAGEN BIOSCIENCE, INC. (NAGE) Gross Margin
- Gross margin · 12 months: Value 64.24%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 64.24% | Gross profit / revenue. Period ending 2026-06-30. $82.92M ÷ $129.08M × 100 ≈ 64.24% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 82.92M USD | Gross Profit |
| Revenue | 129.08M USD | |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $82.92M | $129.08M | (m) | 64.24% |
| 2026-03-31 | $83.83M | $130.42M | (m) | 64.28% |
| 2025-12-31 | $83.19M | $129.42M | (m) | 64.28% |
| 2025-09-30 | $79.68M | $124.71M | (m) | 63.89% |
| 2025-06-30 | $73.99M | $116.30M | (m) | 63.62% |
| 2025-03-31 | $67.46M | $107.92M | (m) | 62.51% |
| 2024-12-31 | $61.59M | $99.60M | (m) | 61.84% |
| 2024-09-30 | $56.33M | $91.67M | (m) | 61.45% |
| 2024-06-30 | $52.05M | $85.58M | (m) | 60.82% |
| 2024-03-31 | $50.72M | $83.17M | (m) | 60.98% |
| 2023-12-31 | $50.78M | $83.57M | (m) | 60.76% |
| 2023-09-30 | $49.86M | $83.37M | (m) | 59.80% |
| 2023-06-30 | $48.10M | $80.94M | (m) | 59.42% |
| 2023-03-31 | $45.78M | $77.35M | (m) | 59.19% |
| 2022-12-31 | $42.80M | $72.05M | (m) | 59.40% |
| 2022-09-30 | $41.65M | $68.81M | (m) | 60.52% |
| 2022-06-30 | $42.02M | $69.06M | (m) | 60.85% |
| 2022-03-31 | $42.79M | $70.03M | (m) | 61.10% |
| 2021-12-31 | $41.49M | $67.45M | (m) | 61.51% |
| 2021-09-30 | $40.04M | $65.14M | (m) | 61.48% |
| 2021-06-30 | $37.92M | $62.01M | (m) | 61.15% |
| 2021-03-31 | $36.20M | $59.59M | (m) | 60.74% |
| 2020-12-31 | $35.27M | $59.26M | (m) | 59.53% |
| 2020-09-30 | $33.32M | $56.90M | (m) | 58.55% |
| 2020-06-30 | $31.61M | $54.77M | (m) | 57.72% |
| 2020-03-31 | $28.78M | $50.59M | (m) | 56.89% |
| 2019-12-31 | $25.77M | $46.29M | (m) | 55.67% |
| 2019-09-30 | $23.02M | $42.27M | (m) | 54.45% |
| 2019-06-30 | $20.63M | $38.34M | (m) | 53.81% |
| 2019-03-31 | $18.22M | $35.04M | (m) | 52.00% |
| 2018-12-31 | $16.05M | $31.56M | (m) | 50.88% |
| 2018-09-30 | $15.18M | (m) | (m) | (m) |
| 2018-06-30 | $13.73M | (m) | (m) | (m) |
| 2018-03-31 | $12.00M | (m) | (m) | (m) |
| 2017-12-30 | $10.48M | (m) | (m) | (m) |
| 2017-09-30 | $10.18M | (m) | (m) | (m) |
| 2017-07-01 | $8.36M | (m) | (m) | (m) |
| 2017-04-01 | $10.22M | (m) | (m) | (m) |
| 2016-12-31 | $11.92M | (m) | (m) | (m) |
| 2016-10-01 | $11.22M | (m) | (m) | (m) |
| 2016-07-02 | $11.66M | (m) | (m) | (m) |
| 2016-04-02 | $10.00M | (m) | (m) | (m) |
| 2016-01-02 | $8.48M | (m) | (m) | (m) |
| 2015-10-03 | $8.30M | (m) | (m) | (m) |
| 2015-07-04 | $7.34M | (m) | (m) | (m) |
| 2015-04-04 | $6.27M | (m) | (m) | (m) |
| 2015-01-03 | $5.33M | (m) | (m) | (m) |
| 2014-09-27 | $4.66M | (m) | (m) | (m) |
| 2014-06-28 | $3.88M | (m) | (m) | (m) |
| 2014-03-29 | $3.45M | (m) | (m) | (m) |
| 2013-12-28 | $3.13M | (m) | (m) | (m) |
| 2013-09-28 | $3.24M | (m) | (m) | (m) |
| 2013-06-29 | $3.75M | (m) | (m) | (m) |
| 2013-03-30 | $3.55M | (m) | (m) | (m) |
| 2012-12-29 | $2.28M | (m) | (m) | (m) |
| 2012-09-29 | $1.82M | (m) | (m) | (m) |
| 2012-07-02 | (m) | (m) | (m) | (m) |
| 2012-06-30 | $1.03M | (m) | (m) | (m) |
| 2012-03-31 | $847.21K | (m) | (m) | (m) |
| 2011-12-31 | $2.47M | (m) | (m) | (m) |
| 2011-10-01 | (m) | (m) | (m) | (m) |
| 2011-07-02 | (m) | (m) | (m) | (m) |
| 2011-04-02 | (m) | (m) | (m) | (m) |
| 2011-01-01 | $2.94M | (m) | (m) | (m) |
| 2010-10-02 | (m) | (m) | (m) | (m) |
| 2010-07-03 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |